The GLP-1 Revolution: How Pills, Dual-Agonists, and Price Competition Are Reshaping Obesity Treatment in 2026
The GLP-1 receptor agonist market — already one of the most transformative stories in modern medicine — entered a radical new chapter in 2026. What was once defined by weekly injections, high prices, and persistent shortages is now rapidly evolving into…